-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Au7FKjbMehr37mJ5sG3IdRetuggRh1xshiV/bkUlTPSY9z/JjWoAkrKfsukS0TJT lwVvZ7QUNE47R2kxNA2KFA== 0001072613-09-000460.txt : 20090305 0001072613-09-000460.hdr.sgml : 20090305 20090305090048 ACCESSION NUMBER: 0001072613-09-000460 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090304 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20090305 DATE AS OF CHANGE: 20090305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 09657378 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 8-K 1 form8-k_16341.htm FORM 8-K DATED MARCH 4, 2009 Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549


FORM 8-K
 
CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 

Date of Report (Date of earliest event reported):   March 4, 2009
 
 

BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
 
 
DELAWARE
1-11083
04-2695240
(State or other jurisdiction of incorporation)
(Commission file number) 
(IRS employer identification no.)
 
 
One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)
 
 
Registrant’s telephone number, including area code:  (508) 650-8000
 
 
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the fling obligation of the registrant under any of the following provisions:

o  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
ITEM 5.02. 
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
   
 
On March 4, 2009, Nancy-Ann DeParle resigned from our Board of Directors in connection with her appointment as Counselor to the President and Director of the White House Office for Health Reform.


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


SIGNATURE


Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

 
BOSTON SCIENTIFIC CORPORATION
  
       
       
Date:       March 5, 2009
By:
/s/ Lawrence J. Knopf  
   
Lawrence J. Knopf 
  
   
Senior Vice President and Deputy General Counsel 
  
       
 
 
 
 
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----